T-cell receptor Vβ gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 2057-2066

  Miyahara, Eiji ^a   Yamaguchi, Yoshiyuki ^a   Minami, Kazuhito ^a   Hihara, Jun ^a   Noma, Kosuke ^a   Toge, Tetsuya ^a   Takafuta, Toshiro ^a   Fujimura, Kingo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cytotoxic T cell clone; Gastric cancer; T cell receptor (TCR); Tumor infiltrating lymphocytes (TIL)

Indexed keywords

CD4 ANTIGEN;

AMINO ACID COMPOSITION; ARTICLE; ASCITES FLUID; CANCER CELL CULTURE; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE STRUCTURE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE CLONE; PRIORITY JOURNAL; SCREENING; SOUTHERN BLOTTING; STOMACH CANCER; T LYMPHOCYTE RECEPTOR GENE; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ASCITES; BLOTTING, SOUTHERN; CLONE CELLS; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; OLIGONUCLEOTIDES; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032815116     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Shimizu Y, Iwatsuki S, Herserman RB, WhitesideTL: Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumor. Int J Cancer 46: 878-883, 1990.
2. Giegerich G, Pette M, Meinl E, Epplen JT, Wekerle H, Hikkanen A: Diversity of T-cell receptor a and b chain genes expressed by human T-cells specific for similar myelin basic protein peptide/major histocompatibility complex. Eur J Immunol 22: 753-759, 1992.
3. Ikeda H, Sato N, Matsuura A, Kikuchi K: Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinoma. Cancer Res 53: 3078-3084, 1993.
4. Chikamatsu K, Eura M, Nakano K, Masuyama K, Ishikawa T: Functional and T cell receptor gene usage analysis of cytotoxic T lymphocytes in fresh tumor-infiltrating lymphocytes from human head and neck cancer. Jpn J Cancer Res 86: 477-483, 1995.
5. Yamaguchi Y, Sato Y, Miyahara E, Noma K, Funakoshi M, Takashima I, Sawamura A, Tetsuya T: Locoregional immunotherapy of malignant ascites by intrapleural administration of OK432 plus IL-2 in gastric cancer patients. Anti Cancer Res 15: 2201-2206, 1995.
6. Ioannides CG, Freedman RS, Platsoucas CD, Rashed S, Kim YP: Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J Immunol 146: 1700-1707, 1991.
7. Shimizu Y, Weidmann E, Iwatsuki S, Herserman RB, Whiteside TL: Characterization of human autotumor-reactive T-cell clone obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res 51: 6153-6162, 1991.
8. Srvastava PK, Deleo AB, Old LJ: Tumor rejection antigens of chemically induced tumors of inbred mice. Proc Nat Acad Sci (Wash.) 3: 3407-3411, 1986.
9. Wolfel T, Herr W, Coulie P, Schmitt U, Meyer zum Buschenfelde KH, Knuth A: Lysis of human pancreatic adenocarcinoma cells by autologous HLA-Class I-restricted cytolytic T-lymphocyte (CTL) clones. Int J Cancer 54: 636-644, 1993.
10. Wolfel T, Hauer M, Klehmann E, Brichatd V, Ackermann B, Knuth A, Boot M: Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes. Int J Cancer 55: 237-244, 1993.
11. Lehmann F, Marchand M, Hainaut P, Pouillart P, Saster X, Ikeda H, Boot T, Coulie PG: Differences in the antigens recognized by cytotoxic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol 25: 340-346, 1995.
12. Davis MM, Bjorkman PJ: T-cell antigen receptor genes and T-cell recognition. Nature 334: 395-402, 1988.
13. Ferradini L, Roman-Roman S, Azocar J, Michalaki H, Triebel F, Hercend T: Studies on the human T-cell receptor a/b variable region genes. II. Identification of four additional Vb subfamilies. Eur J Immunol 21: 935-942, 1991.
14. Roman-Roman S, Ferradini L, Azocar J, Genevee C, Hercend T, Triebel F: Studies on the human T-cell receptor a/b variable region genes. I. Identification of 7 additional Va subfamilies and 14 Ja gene segments. Eur J Immunol 21: 927-933, 1991.
15. Miyahara E, Yamaguchi Y, Hihara J, Noma K, Toge T: Profile of T-cell receptor Vb gene usage of cytotoxic T cells induced by intrapleural administration of streptococcal a preparation, OK432, in malignant effusions. J. Exp. Therapeutic. Oncol 1: 39-48, 1996.
16. Mukherji B, Guha A, Chacraborty NG, Sivanandham M, Nashed AL, Sporn JR, Ergin MT: Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med 169: 1961-1976, 1989.
17. Uchida A, Micksche M: Intrapleural administration of OK-432 in cancer patients: Activation of NK cells and reduction of suppressor cells. Int J Cancer 31: 1-5, 1983.
18. Moretta A, Pantaleo G, Moretta L, Cerottini JC, Mingari MC: Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med 157: 743-754, 1983.
19. Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Permiani G, Anichini A: T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: Tumor-infiltrating lymphocytes overexpress in vivo the TCR b chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J Exp Med 178: 1231-1246, 1993.
20. Romero BP, Pannetier C, Herman J, Jongeneel CV, Cerottini JC, Coulie PG: Multiple specificities in the repertoire of a melanoma patient's cytotoxic T lymphocytes directed against tumor antigen MAGE-1.A1. J Exp Med 182: 1019-1028, 1995.
21. Panzara MA, Gussoni E, Steinman L, Oksenberg JR: Analysis of the T cell receptor using the PCR and specific oligonucleotide primers. BioTechniques 12: 728-735, 1992.
22. Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S, Hercend T: Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 53: 3569-3573, 1993.
23. - double negative T cells. J. Immunol. 173: 1072-108, 1994.
24. Toyonaga B, Yoshikai Y, Vadasz V, Chin B, Mak T: Organization and sequences of the diversity, joining, and constant region gene of the human T-cell receptor b chain. Proc Natl Acad Sci. USA 82: 8624-8628, 1985.
25. Boitel B, Ermonval M, Panina-Bordignon P, Mariuzza RA, Lanzavecchia A, Acuto O: Preferential Vb gene usage and lack of junctional sequence conservation among human T cell receptors specific for a dominant role of a germline-encoded V region in antigen / major histocompatibility complex recognition. J Exp Med 175: 765-777, 1992.
26. Degiovanni G, Lahaye T, Herin M, Hainaut P, Boon T: Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. Eur J Immunol 18: 671-676, 1988.
27. Knuth A, Wolfel T, Klehmann E, Boon T, Meyer zum Buschenfelde KH: Cytotoxic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci USA 86: 2804-2808, 1989.
28. Van den Eynde B, Hainaut P, Herin M, Knuth A, Lemoine C, Weynants P, van der Bruggen P, Fauchet R, Boot T: Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 44: 634-640, 1989.
29. Binz H, Fenner M, Feri D, Wigzell H: Two independent receptors allow selective target lysis by T cell clones. J Exp Med 157: 1252-1260, 1983.
30. Moretta A, Pantaleo G, Mingari MC, Melioli G, Moretta L, Cerottini JC: Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clone lyse specific or NK-sensitive target cell via distinct recognition structures. Eur J Immunol 14: 121-125, 1984.
31. Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins P, Marincola F, Salgaller M, Yannelli J, Appella E, Rosenberg S: Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J Immunol 154: 2257-2265, 1995.
32. Herr W, Wolfel T, Heike M, Meyer zum Buschenfelde KH, Knuth A: Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells. Cancer Immunol. Immunother. 39: 93-99, 1994.